LUMOS DIAGNOSTICS HOLDINGS L(LDX.AU),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

LDX.AU LUMOS DIAGNOSTICS HOLDINGS L

Trading 11-27 10:44:50 AEDT

0.03

+0.00

0.00%

High0.03	Low0.03	Vol10.00K
Open0.03	D1 Closing0.03	Amplitude0.00%
Mkt Cap24.61M	Tradable Cap16.95M	Total Shares745.76M
T/O330.00	T/O Rate0.00%	Tradable Shares513.75M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

{"stockData":{"symbol":"LDX.AU","market":"AU","secType":"STK","nameCN":"LUMOS DIAGNOSTICS HOLDINGS L","latestPrice":0.033,"timestamp":1732663970389,"preClose":0.033,"halted":0,"volume":10000,"delay":0,"nameEN":"LUMOS DIAGNOSTICS HOLDINGS L","floatShares":513749838,"shares":745760037,"eps":-0.02865298972607501,"marketStatus":"Trading","change":0,"latestTime":"11-27 10:44:50 AEDT","open":0.033,"high":0.033,"low":0.033,"amount":330,"amplitude":0,"askPrice":0.033,"askSize":423609,"bidPrice":0.031,"bidSize":131961,"shortable":3,"etf":0,"ttmEps":-0.02865298972607501,"tradingStatus":2,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1732683600000},"marketStatusCode":2,"adr":0,"exchange":"ASX","adjPreClose":0.033,"openAndCloseTimeList":[[1732662000000,1732683600000]],"volumeRatio":0.024156,"lotSize":1,"tradeCurrency":"AUD"},"requestUrl":"/m/hq/s/LDX.AU/wiki","defaultTab":"wiki","newsList":[{"id":"2484987431","title":"Favourable Signals For Lumos Diagnostics Holdings: Numerous Insiders Acquired Stock","url":"https://stock-news.laohu8.com/highlight/detail?id=2484987431","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2484987431?lang=en_us&edition=fundamental","pubTime":"2024-11-19 05:55","pubTimestamp":1731966919,"startTime":"0","endTime":"0","summary":"Usually, when one insider buys stock, it might not be a monumental event. But when multiple insiders are buying like they did in the case of Lumos Diagnostics Holdings Limited , that sends out a positive message to the company's shareholders.Although we don't think shareholders should simply follow insider transactions, we do think it is perfectly logical to keep tabs on what insiders are doing.View our latest analysis for Lumos Diagnostics Holdings. The Last 12 Months Of Insider Transactions At Lumos Diagnostics Holdings. It is good to see recent purchasing. And the longer term insider transactions also give us confidence. But on the other hand, the company made a loss during the last year, which makes us a little cautious. We would certainly prefer see higher levels of insider ownership but analysis of the insider transactio","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/DGkyMqml3gFWOGvNtEHcnA--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/06bbda48bd77be658a8c5765fd6bc2ab","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/DGkyMqml3gFWOGvNtEHcnA--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/06bbda48bd77be658a8c5765fd6bc2ab"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/favourable-signals-lumos-diagnostics-holdings-215519770.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance_au","symbols":["LDX.AU","BK7126"],"gpt_icon":0},{"id":"2479499212","title":"BRIEF-Lumos Diagnostics Posts Unaudited Revenue Of $3.4 Mln For Qtr","url":"https://stock-news.laohu8.com/highlight/detail?id=2479499212","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2479499212?lang=en_us&edition=fundamental","pubTime":"2024-10-29 09:20","pubTimestamp":1730164825,"startTime":"0","endTime":"0","summary":"Oct 29 (Reuters) - Lumos Diagnostics Holdings Ltd :   * UNAUDITED REVENUE OF US$3.4 MILLION FOR QUARTERSource text:    Further company coverage:    ((Reuters.Briefs@thomsonreuters.com;))","market":null,"thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LDX.AU"],"gpt_icon":0},{"id":"2479469054","title":"Lumos Diagnostics  - Unaudited Revenue of US$3.4 Mln for Qtr","url":"https://stock-news.laohu8.com/highlight/detail?id=2479469054","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2479469054?lang=en_us&edition=fundamental","pubTime":"2024-10-29 06:27","pubTimestamp":1730154446,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241028:nFWN3M41QB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LDX.AU","BK7126"],"gpt_icon":0},{"id":"2475808514","title":"Lumos Diagnostics Holdings Limited (ASX:LDX) Stock Catapults 35% Though Its Price And Business Still Lag The Industry","url":"https://stock-news.laohu8.com/highlight/detail?id=2475808514","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2475808514?lang=en_us&edition=fundamental","pubTime":"2024-10-14 08:29","pubTimestamp":1728865740,"startTime":"0","endTime":"0","summary":"Lumos Diagnostics Holdings Limited ( ASX:LDX ) shares have had a really impressive month, gaining 35% after a shaky...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6022000-choice2-main-header/1585186808155","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6022000-choice2-main-header/1585186808155"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/healthcare/asx-ldx/lumos-diagnostics-holdings-shares/news/lumos-diagnostics-holdings-limited-asxldx-stock-catapults-35","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK7126","LDX.AU"],"gpt_icon":0},{"id":"2472394693","title":"ASX Market Close: Index tracks sideways as Real Estate stocks surge | October 3, 2024","url":"https://stock-news.laohu8.com/highlight/detail?id=2472394693","media":"The Market Herald","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2472394693?lang=en_us&edition=fundamental","pubTime":"2024-10-03 14:58","pubTimestamp":1727938680,"startTime":"0","endTime":"0","summary":"The ASX200 closed up less than a tenth of a percent 0.09% at 8,205 points in a flat days trade.All in all, investors continue to assess broad risks associated with escalating tensions in the Middle East.Real Estate stocks performed the best, up more than 1.65%, followed by Telecommunication, up 0.35% and Industrials, up 0.3%. Utilities were the worst performing sector, down 0.4% and Discretionary, down 0.35%.Horizon Minerals  closed up 2.13% after first ore was mined at its Boorara Gold Project near Kalgoorlie, Western Australia. The company expects to pour first gold and mint first revenues very soon.Lumos Diagnostics  closed up more than 16.22% after receiving US$3 million in funding to develop a blood sample test to diagnose if a patient has a bacterial infection.Pilbara Minerals  closed down 4.83% on reports Morgan Stanley and Bank of America executed trades at a 4.1% discount to the value of $270 million before the open. Investors reacted by marking down the stock.Critical mineral","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://themarketonline.com.au/asx-market-close-index-tracks-sideways-as-real-estate-stocks-surge-october-3-2024-2024-10-03/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"markerherald_stock","symbols":["BK4534","BK4588","LU0267386448.USD","LU2357305700.SGD","LU0320765646.SGD","LU0225283273.USD","LU0314104364.USD","LU1668664300.SGD","BK7126","LU0971096721.USD","LU1720051017.SGD","LU1720051108.HKD","BK7504","HRZ.AU","BK4504","IE00BZ1G4Q59.USD","BK7095","LU1548497426.USD","BK4585","BK4127","LU1162221912.USD","LU1989772923.USD","IE00BKVL7J92.USD","LU0106831901.USD","LU1074936037.SGD","BK7507","BK7104","LDX.AU","ETM.AU","LU1989772840.SGD","BK4581","PLS.AU","TVN.AU","LU0098860793.USD","LU1363072403.SGD"],"gpt_icon":0},{"id":"2472540046","title":"Lumos Diagnostics Secures $3 Million BARDA Funding for US Diagnostic Test Study; Shares Climb 11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2472540046","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2472540046?lang=en_us&edition=fundamental","pubTime":"2024-10-03 14:05","pubTimestamp":1727935543,"startTime":"0","endTime":"0","summary":"Lumos Diagnostics  secured nearly $3 million in funding from the Biomedical Advanced Research and Development Authority  in the US for a study on its FebriDx diagnostic test in the country, according to a Thursday filing with the Australian bourse.FebriDx is a point-of-care diagnostic test that can identify if a certain respiratory infection is caused by a bacteria or a virus to ensure proper treatment.BARDA, part of the US Department of Health and Human Services' Administration for Strategic Preparedness and Response, will provide regulatory expertise and support in obtaining a Clinical Laboratory Improvement Amendments waiver from the US Food and Drug Administration for the proposed study.The biotech company's shares climbed almost 11% in recent Thursday trade.Price : $0.04, Change: $+0.004, Percent Change: +10.81%","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4125","BK7126","LDX.AU","AUD"],"gpt_icon":0},{"id":"2472638329","title":"2 ASX healthcare shares rocketing over 16% on Big US news","url":"https://stock-news.laohu8.com/highlight/detail?id=2472638329","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2472638329?lang=en_us&edition=fundamental","pubTime":"2024-10-03 09:07","pubTimestamp":1727917623,"startTime":"0","endTime":"0","summary":"There have been some big moves in the healthcare sector on Thursday.For example, the two ASX healthcare shares listed below are up at least 16% in morning trade thanks to big news in the United States.The Cyclopharm share price is up 18% to $1.80. Investors have been buying the ASX healthcare share this morning after it announced an interim agreement to supply the Veterans Health Administration  with the pharmaceutical and consumable components of Technegas.This could be a very big deal for Cyclopharm given that the VA is the largest integrated US Government health care system in the United States.According to the release, the interim agreement immediately provides the 120 Veterans Affairs hospitals, which have nuclear medicine departments, access to an agreed contract for these products.The ASX healthcare share's CEO and managing director, Doug Ward, commented,Special mention goes to fellow ASX healthcare share Mesoblast Ltd , which is rising over 9% today. However, with no news out o","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.fool.com.au/2024/10/03/2-asx-healthcare-shares-rocketing-over-16-on-big-us-news/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["CYC.AU","LDX.AU","BK7126","BK7501","BK7067","BK7007","MSB.AU","BK7508","CLIA"],"gpt_icon":1},{"id":"2472804816","title":"BRIEF-Lumos Diagnostics And Barda To Partner To Support FebriDx Bacterial/Non-Bacterial Point-Of-Care Test","url":"https://stock-news.laohu8.com/highlight/detail?id=2472804816","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2472804816?lang=en_us&edition=fundamental","pubTime":"2024-10-03 09:04","pubTimestamp":1727917479,"startTime":"0","endTime":"0","summary":"Oct 3  - Lumos Diagnostics Holdings Ltd :   * CO AND BARDA TO PARTNER TO SUPPORT FEBRIDX BACTERIAL/NON-BACTERIAL POINT-OF-CARE TEST   * CO AWARDED $3 MILLION IN NON-DILUTIVE FUNDING FROM BIOMEDICAL ADVANCED RESEARCH AND DEVELOPMENT AUTHORITY   * FUNDING TO SUPPORT COMING FEBRIDX CLIA WAIVER STUDY AND US FDA APPLICATIONFurther company coverage:    ","market":null,"thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LDX.AU","BK7126"],"gpt_icon":0},{"id":"2472680385","title":"BUZZ-Australia's Lumos Diagnostics hits near 4-week high as co gets fresh funds","url":"https://stock-news.laohu8.com/highlight/detail?id=2472680385","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2472680385?lang=en_us&edition=fundamental","pubTime":"2024-10-03 08:56","pubTimestamp":1727917004,"startTime":"0","endTime":"0","summary":"** Shares of Australia's Lumos Diagnostics    rise as much as 16.2% to A$0.043, their highest levels since Sept 6   ** Stock posts its biggest intraday pct gain since Sept 25, on track to record its second straight day of gains, if trend holds    ** The medical equipment supplier says it has been awarded A$3 mln  in funding from Biomedical Advanced Research and Development Authority , part of the U.S. Department of Health and Human Services' administration   ** Funding to support upcoming Lumos' FebriDx CLIA waiver study and the U.S. FDA application    ** FebriDx can aid clinicians with appropriate antibiotic use decisions and will hopefully improve antibiotic stewardship - LDX   ** Near 6.7 mln shares change hands, vs 30-day average volume of 5.4 mln shares   ** Stock has fallen 38.7% this year, as of 0044 GMT     ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7126","LDX.AU"],"gpt_icon":0},{"id":"2472703689","title":"Lumos Diagnostics - Co and Barda to Partner to Support Febridx Bacterial/Non-Bacterial Point-of-Care Test","url":"https://stock-news.laohu8.com/highlight/detail?id=2472703689","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2472703689?lang=en_us&edition=fundamental","pubTime":"2024-10-03 07:33","pubTimestamp":1727912017,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241002:nFWN3LE28L:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LDX.AU","BK7126"],"gpt_icon":0},{"id":"2472689709","title":"Lumos Diagnostics - Co Awarded $3 Mln in Non-Dilutive Funding From Biomedical Advanced Research and Development Authority","url":"https://stock-news.laohu8.com/highlight/detail?id=2472689709","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2472689709?lang=en_us&edition=fundamental","pubTime":"2024-10-03 07:33","pubTimestamp":1727912017,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241002:nFWN3LE28L:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LDX.AU","BK7126"],"gpt_icon":0},{"id":"2472689706","title":"Lumos Diagnostics - Funding to Support Coming Febridx® Clia Waiver Study and US FDA Application","url":"https://stock-news.laohu8.com/highlight/detail?id=2472689706","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2472689706?lang=en_us&edition=fundamental","pubTime":"2024-10-03 07:33","pubTimestamp":1727912017,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241002:nFWN3LE28L:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LDX.AU","BK7126"],"gpt_icon":0},{"id":"2470282146","title":"BRIEF-Lumos Diagnostics Holdings Awarded National Contract With Medigroup","url":"https://stock-news.laohu8.com/highlight/detail?id=2470282146","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2470282146?lang=en_us&edition=fundamental","pubTime":"2024-09-25 16:09","pubTimestamp":1727251781,"startTime":"0","endTime":"0","summary":"Sept 25 (Reuters) - Lumos Diagnostics Holdings Ltd :   * LUMOS AWARDED NATIONAL CONTRACT WITH MEDIGROUP FOR FEBRIDX Further company coverage:    ((Reuters.Briefs@thomsonreuters.com;))","market":null,"thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7126","LDX.AU"],"gpt_icon":0},{"id":"2470234470","title":"BUZZ-Australia's Lumos Diagnostics set for best day in 8-1/2 months on US contract win","url":"https://stock-news.laohu8.com/highlight/detail?id=2470234470","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2470234470?lang=en_us&edition=fundamental","pubTime":"2024-09-25 11:21","pubTimestamp":1727234461,"startTime":"0","endTime":"0","summary":"** Shares of Lumos Diagnostics Holdings    rise as much as 23.4% to A$0.042, set for best day since Jan. 11 - if current gains hold     ** Medical equipment manufacturer announces placement of its respiratory test FebriDx on the U.S. MediGroup national contract   ** Says MediGroup is single largest non-acute care group purchasing organisaton, which oversees equipment procurement for healthcare providers   ** FebriDx evaluates respiratory infection in a patient during emergency care   ** Shares hit highest level since Sept 9    ** LDX down 44.5% YTD, including day's moves  ","market":null,"thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LDX.AU","BK7126","XKO.AU","XAO.AU","XJO.AU"],"gpt_icon":0},{"id":"2470471790","title":"Lumos Diagnostics Holdings Ltd - Lumos Awarded National Contract With Medigroup for Febridx","url":"https://stock-news.laohu8.com/highlight/detail?id=2470471790","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2470471790?lang=en_us&edition=fundamental","pubTime":"2024-09-25 10:23","pubTimestamp":1727231007,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20240925:nFWN3L60WV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7126","LDX.AU"],"gpt_icon":0},{"id":"2467855336","title":"BRIEF-Lumos Diagnostics Holdings Appoints Thermo Fisher Scientific As US Distributor For Febridx","url":"https://stock-news.laohu8.com/highlight/detail?id=2467855336","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2467855336?lang=en_us&edition=fundamental","pubTime":"2024-09-16 07:34","pubTimestamp":1726443241,"startTime":"0","endTime":"0","summary":"Sept 16 (Reuters) - Lumos Diagnostics Holdings Ltd :   * LUMOS APPOINTS THERMO FISHER SCIENTIFIC AS US DISTRIBUTOR FOR FEBRIDXFurther company coverage:    ((Reuters.Briefs@thomsonreuters.com;))","market":null,"thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LDX.AU","BK7126"],"gpt_icon":0},{"id":"2467285303","title":"Lumos Diagnostics Holdings Ltd - Lumos Appoints Thermo Fisher Scientific as US Distributor for Febridx","url":"https://stock-news.laohu8.com/highlight/detail?id=2467285303","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2467285303?lang=en_us&edition=fundamental","pubTime":"2024-09-16 07:28","pubTimestamp":1726442922,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20240915:nFWN3KV0XA:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LDX.AU","BK7126"],"gpt_icon":0},{"id":"2466440048","title":"Lumos Diagnostics Opens Retail Entitlement Offer; Shares Down 5%","url":"https://stock-news.laohu8.com/highlight/detail?id=2466440048","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2466440048?lang=en_us&edition=fundamental","pubTime":"2024-09-11 11:55","pubTimestamp":1726026917,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_live","symbols":["AUD","BK4125","XKO.AU","BK7126","XJO.AU","XAO.AU","LDX.AU"],"gpt_icon":0},{"id":"2466017440","title":"Lumos Diagnostics Opens Retail Entitlement Offer; Shares Down 5%","url":"https://stock-news.laohu8.com/highlight/detail?id=2466017440","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2466017440?lang=en_us&edition=fundamental","pubTime":"2024-09-11 11:55","pubTimestamp":1726026917,"startTime":"0","endTime":"0","summary":"Lumos Diagnostics Holdings  opened the retail component of its one-for-1.82 accelerated non-renounceable pro-rata entitlement offer, according to a filing with the Australian bourse.The offer has an issue price of AU$0.038 per share, with about 264.5 million new shares to be issued.It is led, managed, and underwritten by Bell Potter Securities up to AU$6.1 million.The offer will close on Oct. 2.The diagnostic test technology company's shares were down more than 5% in recent Wednesday trade.Price : $0.04, Change: $-0.0020, Percent Change: -5.41%","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7126","AUD","LDX.AU","BK4125"],"gpt_icon":0},{"id":"2466641305","title":"Lumos Diagnostics Holdings Ltd-Retail Entitlement Offer Opens","url":"https://stock-news.laohu8.com/highlight/detail?id=2466641305","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2466641305?lang=en_us&edition=fundamental","pubTime":"2024-09-11 07:01","pubTimestamp":1726009271,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20240910:nTUE4KKPSB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LDX.AU","BK7126"],"gpt_icon":0}],"profile":{"stockEarnings":[{"period":"1week","weight":0.1},{"period":"1month","weight":-0.2143},{"period":"3month","weight":-0.175},{"period":"6month","weight":-0.0833},{"period":"1year","weight":-0.5},{"period":"ytd","weight":-0.5479}],"compareEarnings":[{"period":"1week","weight":0.0091},{"period":"1month","weight":-0.0106},{"period":"3month","weight":-0.0169},{"period":"6month","weight":0.0382},{"period":"1year","weight":0.1487},{"period":"ytd","weight":0.1373}],"compareStock":{"symbol":"F100.AU","name":"BETASHARES FTSE 100 ETF"},"yearOnYearQuotes":[{"month":1,"riseRate":0.333333,"avgChangeRate":0.039403},{"month":2,"riseRate":0,"avgChangeRate":-0.277253},{"month":3,"riseRate":0,"avgChangeRate":-0.210181},{"month":4,"riseRate":0,"avgChangeRate":-0.277299},{"month":5,"riseRate":0,"avgChangeRate":-0.244225},{"month":6,"riseRate":0.666667,"avgChangeRate":1.354078},{"month":7,"riseRate":0.5,"avgChangeRate":0.204507},{"month":8,"riseRate":0.25,"avgChangeRate":-0.082827},{"month":9,"riseRate":0,"avgChangeRate":-0.103687},{"month":10,"riseRate":0.25,"avgChangeRate":-0.064797},{"month":11,"riseRate":0.666667,"avgChangeRate":0.088717},{"month":12,"riseRate":0.333333,"avgChangeRate":-0.137345}],"exchange":"ASX","name":"LUMOS DIAGNOSTICS HOLDINGS L","nameEN":"LUMOS DIAGNOSTICS HOLDINGS L"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"LUMOS DIAGNOSTICS HOLDINGS L(LDX.AU),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest LUMOS DIAGNOSTICS HOLDINGS L(LDX.AU) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"LUMOS DIAGNOSTICS HOLDINGS L,LDX.AU,LUMOS DIAGNOSTICS HOLDINGS L股票,LUMOS DIAGNOSTICS HOLDINGS L股票老虎,LUMOS DIAGNOSTICS HOLDINGS L股票老虎国际,LUMOS DIAGNOSTICS HOLDINGS L行情,LUMOS DIAGNOSTICS HOLDINGS L股票行情,LUMOS DIAGNOSTICS HOLDINGS L股价,LUMOS DIAGNOSTICS HOLDINGS L股市,LUMOS DIAGNOSTICS HOLDINGS L股票价格,LUMOS DIAGNOSTICS HOLDINGS L股票交易,LUMOS DIAGNOSTICS HOLDINGS L股票购买,LUMOS DIAGNOSTICS HOLDINGS L股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"LUMOS DIAGNOSTICS HOLDINGS L(LDX.AU),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest LUMOS DIAGNOSTICS HOLDINGS L(LDX.AU) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction